BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38693256)

  • 21. Aggressiveness features and outcomes of true interval cancers: comparison between screen-detected and symptom-detected cancers.
    Domingo L; Blanch J; Servitja S; Corominas JM; Murta-Nascimento C; Rueda A; Redondo M; Castells X; Sala M
    Eur J Cancer Prev; 2013 Jan; 22(1):21-8. PubMed ID: 22584215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain.
    Domingo L; Salas D; Zubizarreta R; Baré M; Sarriugarte G; Barata T; Ibáñez J; Blanch J; Puig-Vives M; Fernández A; Castells X; Sala M;
    Breast Cancer Res; 2014 Jan; 16(1):R3. PubMed ID: 24410848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screen-detected versus interval cancers: Effect of imaging modality and breast density in the Flemish Breast Cancer Screening Programme.
    Timmermans L; Bleyen L; Bacher K; Van Herck K; Lemmens K; Van Ongeval C; Van Steen A; Martens P; De Brabander I; Goossens M; Thierens H
    Eur Radiol; 2017 Sep; 27(9):3810-3819. PubMed ID: 28289944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program.
    Baré M; Torà N; Salas D; Sentís M; Ferrer J; Ibáñez J; Zubizarreta R; Sarriugarte G; Barata T; Domingo L; Castells X; Sala M
    Breast Cancer Res Treat; 2015 Nov; 154(2):403-15. PubMed ID: 26531756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiological and pathological findings of interval cancers in a multi-centre, randomized, controlled trial of mammographic screening in women from age 40-41 years.
    Evans AJ; Kutt E; Record C; Waller M; Bobrow L; Moss S
    Clin Radiol; 2007 Apr; 62(4):348-52. PubMed ID: 17331828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of prior mammography with negative result in women with interval breast cancer.
    Choi WJ; Cha JH; Kim HH; Shin HJ; Chae EY
    Breast Cancer; 2016 Jul; 23(4):583-9. PubMed ID: 25820217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screen-detected and interval breast cancer after concordant and discordant interpretations in a population based screening program using independent double reading.
    Martiniussen MA; Sagstad S; Larsen M; Larsen ASF; Hovda T; Lee CI; Hofvind S
    Eur Radiol; 2022 Sep; 32(9):5974-5985. PubMed ID: 35364710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study.
    Zackrisson S; Lång K; Rosso A; Johnson K; Dustler M; Förnvik D; Förnvik H; Sartor H; Timberg P; Tingberg A; Andersson I
    Lancet Oncol; 2018 Nov; 19(11):1493-1503. PubMed ID: 30322817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk for distant recurrence of breast cancer detected by mammography screening or other methods.
    Joensuu H; Lehtimäki T; Holli K; Elomaa L; Turpeenniemi-Hujanen T; Kataja V; Anttila A; Lundin M; Isola J; Lundin J
    JAMA; 2004 Sep; 292(9):1064-73. PubMed ID: 15339900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumour characteristics of screen-detected and interval cancers in the Flemish Breast Cancer Screening Programme: A mammographic breast density study.
    Timmermans L; De Brabander I; Van Damme N; Bleyen L; Martens P; Van Herck K; Thierens H; Bacher K; Depypere H
    Maturitas; 2022 Apr; 158():55-60. PubMed ID: 35241239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Additional Breast Cancer Detection at Digital Screening Mammography through Quality Assurance Sessions between Technologists and Radiologists.
    Coolen AMP; Korte B; Tjan-Heijnen VCG; Bodewes HW; Voogd AC; Duijm LEM
    Radiology; 2020 Mar; 294(3):509-517. PubMed ID: 31909697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of review design on percentages of missed interval breast cancers: retrospective study of interval cancers in a population-based screening program.
    Hofvind S; Skaane P; Vitak B; Wang H; Thoresen S; Eriksen L; Bjørndal H; Braaten A; Bjurstam N
    Radiology; 2005 Nov; 237(2):437-43. PubMed ID: 16244251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of artificial intelligence-based triaging of breast cancer screening mammograms on cancer detection and radiologist workload: a retrospective simulation study.
    Dembrower K; Wåhlin E; Liu Y; Salim M; Smith K; Lindholm P; Eklund M; Strand F
    Lancet Digit Health; 2020 Sep; 2(9):e468-e474. PubMed ID: 33328114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AI-based prevention of interval cancers in a national mammography screening program.
    Byng D; Strauch B; Gnas L; Leibig C; Stephan O; Bunk S; Hecht G
    Eur J Radiol; 2022 Jul; 152():110321. PubMed ID: 35512511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Digital compared to screen-film mammography: breast cancer prognostic features in an organized screening program.
    Prummel MV; Done SJ; Muradali D; Majpruz V; Brown P; Jiang H; Shumak RS; Yaffe MJ; Holloway CM; Chiarelli AM
    Breast Cancer Res Treat; 2014 Sep; 147(2):389-99. PubMed ID: 25108740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program.
    Kirsh VA; Chiarelli AM; Edwards SA; O'Malley FP; Shumak RS; Yaffe MJ; Boyd NF
    J Natl Cancer Inst; 2011 Jun; 103(12):942-50. PubMed ID: 21540443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AI Risk Score on Screening Mammograms Preceding Breast Cancer Diagnosis.
    Larsen M; Olstad CF; Koch HW; Martiniussen MA; Hoff SR; Lund-Hanssen H; Solli HS; Mikalsen KØ; Auensen S; Nygård J; Lång K; Chen Y; Hofvind S
    Radiology; 2023 Oct; 309(1):e230989. PubMed ID: 37847135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term prognosis of breast cancer detected by mammography screening or other methods.
    Lehtimäki T; Lundin M; Linder N; Sihto H; Holli K; Turpeenniemi-Hujanen T; Kataja V; Isola J; Joensuu H; Lundin J
    Breast Cancer Res; 2011; 13(6):R134. PubMed ID: 22204661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mammographic characteristics of 115 missed cancers later detected with screening mammography and the potential utility of computer-aided detection.
    Birdwell RL; Ikeda DM; O'Shaughnessy KF; Sickles EA
    Radiology; 2001 Apr; 219(1):192-202. PubMed ID: 11274556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interval breast cancers: absolute and proportional incidence and blinded review in a community mammographic screening program.
    Carbonaro LA; Azzarone A; Paskeh BB; Brambilla G; Brunelli S; Calori A; Caumo F; Malerba P; Menicagli L; Sconfienza LM; Vadalà G; Brambilla G; Fantini L; Ciatto S; Sardanelli F
    Eur J Radiol; 2014 Feb; 83(2):e84-91. PubMed ID: 24369953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.